跳至主要内容
临床试验/NCT05367050
NCT05367050Unknown不适用

Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids.

Lucid Lane, Inc2 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2021年5月4日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
103
试验地点
2
主要终点
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) or Hip Injury and Osteoarthritis Outcome Score (HOOS) and

研究概览

简要总结

The quality of recovery after surgery is multi-factorial and includes both physical and mental factors. Persistent pain after surgery is a common problem after major surgery and can result in persistent opioid use. The investigators will be evaluating if the addition of a pain coach/councilor before and after surgery, through a tele health platform (LucidLane) can improve participant's recovery from major joint surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients between the ages of 21-90 years old
  • Patient is opioid naive i.e hasn't used opioid medication for 30 days prior to surgery
  • Patient willing to use Lucid Lane program to provide behavioral health support for up to 4 weeks before surgery and 4 weeks after surgery.
  • Patient is willing to discuss Lucid Lane progress with Palo Alto VA's medical team and prescribing clinicians.
  • Patient is willing to sign a Lucid Lane Client Agreement.
  • Patient is willing to sign an informed consent form

排除标准

  • Serious mental illnesses including schizophrenia-spectrum disorders, severe bipolar disorder, and severe major depression.
  • Active suicidal ideations
  • Patient is on methadone or buprenorphine for treatment of opioid use disorder(i.e. for treatment of addiction, and not for treatment of pain)
  • Patient unwilling to use or not possessing access to a device that allows for video visits(e.g. a smart phone, tablet, or computer)
  • Patients who are in palliative care
  • Unable to use English to participate in the consent process, the intervention or study assessments.
  • Unable to provide informed consent to participate

结局指标

主要结局

Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) or Hip Injury and Osteoarthritis Outcome Score (HOOS) and

时间窗: Up to 4 months

The KOOS and HOOS are questionnaires designed to assess short and long-term patient-relevant outcomes following knee/hip injury. They are self-administered and assess five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee/hip-related quality of life. The scores are normalized on a scale of 0 to 100, where 0 indicates severe problems and 100 indicates no problems.

Change in Depression Scores

时间窗: Up to 4 months

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self administered questionnaire used to screen and monitor the severity of depressive symptoms. It inquires about depressive features, that align with the diagnostic and statistical manual of mental disorders, over the course of 2 weeks. Responses are recorded on a scale of 0-3, where 0 represents absence of the symptom and 3 represents its presence nearly every day.

Change in Pain Catastrophizing scale

时间窗: Up to 4 months

The Pain catastrophizing scale (PCS) is a self administered, 13-item questionnaire, used to assess a patient's tendency to magnify the threat value of a pain stimulus. It assess rumination, magnification and helplessness. Responses are recorded on a scale of 0-4, where 0 represents absence of the thought and 4 represents the presence of the thought all the time. The scale has a min score of 0 and a max score of 52. A higher score indicates more pain catastrophizing .

Change in Anxiety Scores

时间窗: Up to 4 months

The General Anxiety Disorder-7 (GAD-7) is a self administered, 7-item questionnaire used to measure general anxiety disorder and its severity. Responses are recorded on a scale of 0-3, where 0 represents an absence of the symptom and 3 represents presence nearly every day.

次要结局

  • Percent tapered off opioid (50% MME)(4 weeks after surgery)

研究者

发起方
Lucid Lane, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验